+Search query
-Structure paper
Title | Ultrapotent neutralizing antibodies against SARS-CoV-2 with a high degree of mutation resistance. |
---|---|
Journal, issue, pages | J. Clin. Invest., Vol. 132, Year 2022 |
Publish date | Jul 15, 2021 (structure data deposition date) |
![]() | Zou, J. / Li, L. / Zheng, P. / Liang, W. / Hu, S. / Zhou, S. / Wang, Y. / Zhao, J. / Yuan, D. / Liu, L. ...Zou, J. / Li, L. / Zheng, P. / Liang, W. / Hu, S. / Zhou, S. / Wang, Y. / Zhao, J. / Yuan, D. / Liu, L. / Wu, D. / Xu, M. / Zhang, F. / Zhu, M. / Wu, Z. / Cao, X. / Ni, M. / Ling, X. / Wu, Y. / Kuang, Z. / Hu, M. / Li, J. / Li, X. / Guo, X. / Xu, T. / Jiang, H. / Gao, C. / Yu, M. / Liu, J. / Zhong, N. / Zhou, J. / Huang, J.A. / Jin, T. / He, J. |
![]() | ![]() ![]() |
Methods | X-ray diffraction |
Resolution | 1.89 - 2.4 Å |
Structure data | ![]() PDB-7fcp: ![]() PDB-7fcq: |
Chemicals | ![]() ChemComp-TRS: ![]() ChemComp-NAG: ![]() ChemComp-GOL: ![]() ChemComp-HOH: |
Source |
|
![]() | ANTIVIRAL PROTEIN / SARS-CoV-2 / RBD / neutralizing antibodies |